Author name: Michael Brugmann

Walking into the research peptide space for the first time can feel like learning a new language. Acronyms stack up fast, and product catalogs are often organized in ways that assume you already know what you’re looking for. This post breaks down the major functional categories so you can navigate with more context. GLP-1s / Metabolic Compounds GLP-1 receptor agonists are peptides studied for their role in glucose regulation and metabolic pathways. This category has seen enormous research interest in recent years, and it’s often the entry point for people discovering the space. Compounds here are typically studied in the context of metabolic and endocrine research models. GHRPs (Growth Hormone Releasing Peptides) GHRPs are a class of peptides studied for their interaction with the ghrelin receptor and their downstream effects on growth hormone secretion. They’re a distinct mechanism from GLP-1s and are often researched in combination with growth hormone releasing hormone (GHRH) analogs to study synergistic effects on the GH axis. Healing & Recovery Compounds This category covers peptides studied for their roles in tissue repair, wound healing, and recovery processes at the cellular level. Research here spans everything from gut-lining studies to connective tissue and inflammatory response models. Longevity Compounds Longevity-focused research peptides are studied in the context of cellular aging, senescence, and related biological pathways. This is one of the fastest-moving areas of peptide research, with new mechanistic studies published regularly. Focus / Cognitive Compounds This group includes peptides studied for their interaction with neurological pathways, often in the context of cognitive performance and neuroprotection research models. Why Categories Matter Understanding these groupings isn’t just a navigation convenience — it reflects real differences in mechanism of action, receptor targets, and the type of research questions each compound is suited to answer. Two peptides that sound similar on the surface can work through completely different biological pathways. How to Choose Where to Start If you’re new to a particular research area, start by identifying the specific mechanism or pathway your research question is centered on, then work backward to the compound category that matches. Every product page includes documentation on mechanism of action to help with that process, and our team is always available if you want a second opinion before ordering. This content is provided for general research and educational purposes only.

When a researcher orders a vial of lyophilized peptide, it arrives as a white or off-white powder that looks remarkably unremarkable. But the process that produced that powder — from raw amino acid building blocks to a purified, quality-tested compound — is a precise and technically demanding scientific endeavor. Understanding how peptides are made helps researchers evaluate the quality of what they’re working with and ask better questions of their suppliers. This article walks through the full journey of a synthetic peptide: from synthesis to purification, lyophilization, and final quality release. Solid-Phase Peptide Synthesis: The Foundation Virtually all research-grade synthetic peptides today are produced using a method called Solid-Phase Peptide Synthesis (SPPS), a technique pioneered by biochemist R. Bruce Merrifield in the 1960s for which he was awarded the Nobel Prize in Chemistry in 1984. The elegance of SPPS lies in its stepwise, controllable approach to building peptide chains. The process works as follows: a solid, insoluble resin bead serves as the anchor point for the growing peptide chain. Amino acids are added sequentially, one at a time, in the exact order specified by the target peptide sequence. Each coupling step involves: This cycle repeats for each amino acid in the sequence. A peptide with 20 amino acids requires approximately 20 full cycles, each of which must proceed with high efficiency to prevent incomplete sequences and deletion errors from accumulating. Why this matters: Each coupling step has an efficiency — often 99% or better in well-run synthesis. But across 20 steps, a 99% efficiency means only about 82% of chains are complete and correct. This is why purification after synthesis is not optional — it is essential. Protecting Groups: The Chemistry Behind Selectivity Amino acids have multiple reactive sites — not just the terminal ends that should be linked during synthesis, but also functional groups on their side chains. Without protection, these side chains would react unpredictably during synthesis, producing a chaotic mixture of products. The solution is protecting groups: chemical modifications that temporarily block reactive sites on amino acids until they are needed. There are two dominant strategies in modern SPPS: The choice of strategy affects the final product’s characteristics and the types of residual chemical impurities that may be present — which is one reason why the COA’s HPLC chromatogram is so informative for a knowledgeable researcher. Cleavage and Global Deprotection Once all amino acids have been coupled, the completed peptide chain must be cleaved from the resin and fully deprotected. This is accomplished using a cocktail of cleavage reagents — typically trifluoroacetic acid (TFA) as the primary cleavage agent combined with various scavengers to neutralize the reactive species generated during deprotection. The crude product at this stage is a mixture of the desired full-length peptide, truncated sequences, deletion products, and various chemical byproducts. In the best-run synthesis operations, the crude purity of the target peptide might be 60-80% before purification. In poorly optimized synthesis, it can be considerably lower. Purification: Where Quality Is Established The transformation from crude synthesis product to research-grade peptide happens during purification, primarily using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). This method separates molecules based on their hydrophobicity — essentially how strongly they interact with the non-polar stationary phase of the column versus the aqueous mobile phase flowing through it. Because each peptide sequence has a unique combination of hydrophobic and hydrophilic amino acids, the target compound elutes from the column at a characteristic time (the retention time), separating it from truncated sequences and other impurities that behave differently. Fractions containing the target peptide are collected and pooled. For research-grade peptides, this purification step should achieve purity levels of 98% or greater, with premium products reaching 99%+. Higher purity requires more careful fraction collection and may involve multiple purification passes, which is part of why higher-purity peptides command a price premium. Important context: The HPLC chromatogram on a COA is a direct readout of the purification result. A single clean peak with minimal shoulder peaks or baseline impurities is the hallmark of a well-purified peptide. Any COA worth reviewing should include this chromatogram, not just the purity percentage number. Salt Form and Counterions After TFA-based cleavage and purification, most peptides exist as a TFA salt — trifluoroacetate ions are bound as counterions to the positively charged residues in the peptide. For many research applications this is acceptable, but TFA itself has mild cytotoxic properties that can interfere with cell-based studies. Higher-quality suppliers will perform a salt conversion step, replacing TFA counterions with acetate ions through a secondary HPLC purification using ammonium acetate buffer. The resulting acetate salt form is generally preferred for cell culture work and in vitro research. COAs for quality peptides should specify the salt form. Lyophilization: The Final Step Before the Vial Once purified, the peptide solution is prepared for long-term storage through lyophilization — also known as freeze-drying. The process removes water under vacuum at low temperatures, converting the peptide from an aqueous solution to the dry powder that researchers receive in their vials. Lyophilization preserves peptide stability significantly better than liquid storage. Most peptides in lyophilized form can be stored at -20°C for 1-2 years without significant degradation, whereas reconstituted peptide solutions are typically only stable for days to weeks under refrigeration. The lyophilized powder is then accurately weighed and filled into vials under controlled conditions. The fill weight should match the labeled amount within a tight tolerance — typically ±5% for a quality producer. Why Understanding This Matters for Researchers Knowing the synthesis and production process helps researchers in several practical ways: The Northwest Compounds Commitment Every peptide we offer has traveled this full journey — from precise SPPS synthesis through thorough purification and third-party quality testing — before it reaches our customers. We believe that researchers who understand this process make better decisions about what they order, how they use it, and how they interpret their results. Transparency about the production process is not just good practice — it is a mark of respect for the

If you’ve spent any time reading about biochemistry, sports science, or regenerative research, you’ve likely come across the word peptide. But what exactly are peptides, and why have they become such a focal point of modern research? This article breaks it down clearly so anyone — from a curious newcomer to a seasoned researcher — can understand what’s going on at the molecular level. The Building Blocks: Amino Acids and Peptide Bonds To understand peptides, you first need to understand amino acids. Amino acids are small organic molecules that serve as the fundamental units of all proteins in living organisms. The human body uses 20 standard amino acids, each with a slightly different chemical side chain that gives it unique properties. When two or more amino acids link together through a chemical connection called a peptide bond, the resulting molecule is called a peptide. The distinction between a peptide and a protein is largely one of size: peptides typically contain fewer than 50 amino acids, while proteins are longer chains. Short peptides — those with just two or three amino acids — are called dipeptides and tripeptides respectively. Longer chains of up to 50 units are often called polypeptides. This structural simplicity is part of what makes peptides so interesting to researchers. They are small enough to be synthesized precisely in a laboratory setting, yet complex enough to interact meaningfully with the body’s biological systems. How Peptides Function in the Body The human body naturally produces thousands of peptides that serve critical functions. These endogenous peptides act as signaling molecules, hormones, neurotransmitters, and structural components. Some familiar examples include: Insulin — a peptide hormone that regulates blood glucose levels Oxytocin — a neuropeptide involved in social bonding and childbirth Glucagon — a peptide that signals the liver to release stored glucose Endorphins — peptides that modulate pain perception and mood What these examples illustrate is that peptides are not exotic foreign substances — they are part of the body’s own signaling language. Synthetic peptides studied in research settings are often designed to mimic, modulate, or investigate these natural processes. Peptide Research: A Broad Scientific Landscape Academic and institutional research involving peptides spans an enormous range of disciplines. Below are several areas where peptide-based molecules have attracted significant scientific interest: Growth Hormone Secretagogues A large category of research peptides involves molecules that interact with the growth hormone axis. These include peptides that stimulate the pituitary gland to release growth hormone (GH), or that mimic the action of growth hormone-releasing hormone (GHRH). Scientists study these compounds in the context of metabolism, body composition, tissue repair, sleep quality, and aging. Examples include peptides in the GHRH analogue class as well as ghrelin receptor agonists. Tissue Repair and Regeneration Some of the most extensively published peptide research involves tissue repair and wound healing. Certain short peptide sequences appear to influence inflammatory signaling pathways, promote angiogenesis (the formation of new blood vessels), and modulate collagen synthesis. These properties have made them subjects of interest in orthopedic, dermatological, and gastrointestinal research. Metabolic Research The global interest in obesity, metabolic disease, and body weight regulation has fueled significant research into peptides that interact with GLP-1 receptors, GIP receptors, and related pathways. Several pharmaceutical-grade GLP-1 receptor agonists now exist as approved drugs, but researchers continue to study novel peptide molecules with similar or complementary mechanisms of action to better understand metabolic physiology. Cognitive and Neuroprotective Research Peptides derived from brain tissue or designed to cross the blood-brain barrier have been studied for their potential neuroprotective and nootropic properties. Research in this space examines how peptide compounds may influence neuroplasticity, nerve growth factor activity, and cognitive function under various experimental conditions. Antimicrobial Peptides In the era of growing antibiotic resistance, antimicrobial peptides (AMPs) represent a promising area of investigation. These naturally occurring and synthetic short peptide sequences have demonstrated the ability to disrupt bacterial cell membranes in laboratory studies, making them candidates for future therapeutic development. Skin, Collagen, and Cosmetic Science Peptides like GHK-Cu (copper peptide) and various collagen-stimulating sequences have been studied extensively in dermatological and cosmetic research. Their ability to influence fibroblast activity, collagen and elastin production, and wound healing has made them subjects of both academic papers and commercial skin care formulations. How Synthetic Peptides Are Made Modern peptides used in research are almost exclusively produced through a process called solid-phase peptide synthesis (SPPS). In this method, amino acids are added one at a time to a solid resin support, building the peptide chain in a controlled sequence. After synthesis, the peptide is cleaved from the resin, purified — typically using high-performance liquid chromatography (HPLC) — and tested for identity and purity. The precision of this process means that researchers can obtain highly specific molecules with known sequences and purity levels. This is critical for reproducible experimental results and is part of why quality testing (which we’ll cover in a future article) is so important in the research community. The Research Use Only (RUO) Designation It’s important to understand that peptides sold through companies like Northwest Compounds carry a Research Use Only (RUO) designation. This means they are intended strictly for laboratory and scientific research purposes. RUO products exist within a framework that supports academic and institutional research, but they are not approved drugs and should not be treated as such. Researchers who work with RUO peptides are expected to understand applicable regulations, institutional guidelines, and best practices for handling research-grade materials. Why Peptides Matter to Modern Science The explosion of interest in peptides over the past two decades reflects a broader shift in how scientists think about biology. Rather than searching exclusively for small-molecule drugs that block or activate single targets, researchers are increasingly interested in molecules that work more like the body’s own signaling systems — selectively, with defined mechanisms, and often with high specificity. Peptides sit at a fascinating intersection of biochemistry, pharmacology, and molecular biology. Their relatively small size makes them easier to synthesize and study than full proteins, while their

The research peptide market has grown substantially over the past decade, and with that growth has come an unfortunate proliferation of low-quality, inconsistently tested, and sometimes outright mislabeled products. For researchers who depend on the accuracy and reliability of their compounds, understanding what separates a trustworthy source from a questionable one is not a minor concern — it is fundamental to the integrity of the work. This article breaks down what a genuine Certificate of Analysis (COA) should contain, why endotoxin testing is a non-negotiable quality marker, and what purity standards researchers should expect from any reputable supplier. What Is a Certificate of Analysis? A Certificate of Analysis (COA) is a document issued by a laboratory — ideally a third-party, accredited testing facility — that reports the analytical results for a specific batch of compound. It serves as the primary quality documentation for any research-grade chemical or peptide. A COA is only as trustworthy as the lab that produced it. Reputable suppliers use accredited third-party laboratories rather than relying on in-house testing alone. The lab should be identifiable, verifiable, and ideally ISO 17025 accredited — the international standard for testing and calibration laboratories. Key principle: If a supplier cannot provide a COA from a named, verifiable third-party laboratory, that is a significant red flag. The Bare Minimum vs. What You Actually Need Many suppliers in the RUO peptide space provide what appears to be thorough documentation but is actually quite limited. The most common approach is to report only two values: While both of these tests are necessary, they are not sufficient on their own. A peptide can pass a basic mass and purity check while still containing contaminants that are invisible to those two methods — and some of those contaminants pose serious problems for research integrity. Common COA Testing: What Each Method Tells You Test Method What It Detects What It Misses Importance Level HPLC Purity Target peptide percentage vs. impurities Biological contaminants, endotoxins Essential Mass Spectrometry (MS) Molecular weight / identity confirmation Quantity, purity percentage, biologics Essential Endotoxin (LAL/rFC) Bacterial lipopolysaccharide (LPS) levels N/A — this IS what it’s for Critical Sterility Testing Microbial contamination (bacteria, fungi) Non-viable contaminants Important Water Content (Karl Fischer) Residual moisture in lyophilized peptide Does not measure other impurities Relevant   Why Endotoxin Testing Is Critical Endotoxins — specifically lipopolysaccharides (LPS) — are fragments of the outer membrane of gram-negative bacteria. They are extraordinarily potent immune system activators, even in very small quantities. In research applications where peptides are being used in cell culture assays, in vitro studies, or animal research, endotoxin contamination is a major confounding variable. Here is why this matters so much in practice: The standard assay for endotoxin testing is the Limulus Amebocyte Lysate (LAL) test, or its recombinant equivalent (rFC assay). These tests detect LPS concentrations down to the picogram-per-milliliter level. The FDA-recognized limit for injectable pharmaceutical products is 5 EU/kg body weight per hour, though research applications often aim for even lower thresholds. Bottom line: A supplier who does not include endotoxin testing in their COA is either cutting costs or doesn’t understand why it matters. Either answer should concern you. Purity Standards: Why >99% Is the Benchmark When peptide purity is reported on a COA, it typically refers to the percentage of the desired peptide present in the final product by HPLC area. A purity of 99% or greater is the gold standard for research-grade peptides, and here’s why that extra 1% matters enormously: In a 10 mg vial of a peptide with 95% purity, approximately 0.5 mg of the contents is comprised of unknown impurities. Those impurities could include truncated sequences, oxidized variants, deletion sequences from synthesis errors, or residual solvents from the purification process. In a tightly controlled experiment where precise dosing is critical, this level of contamination introduces meaningful uncertainty into your results. At 99%+ purity, the researcher can have substantially more confidence that observed biological effects are attributable to the intended compound, not to poorly characterized contaminants. For cell-based assays in particular — where even small amounts of cytotoxic byproducts can skew viability data — this distinction is significant. What to Look for in a Reputable Source When evaluating a peptide supplier for research purposes, the COA is the most important document you will review. Here is a practical checklist: A Note on Transparency One of the most telling signs of a trustworthy supplier is proactive transparency. Companies that publish their COAs publicly, link them to specific product lots, and use readily verifiable laboratories are demonstrating that they have nothing to hide. By contrast, suppliers who provide COAs only upon request, whose documentation lacks lot numbers, or whose named testing facilities cannot be independently verified should be approached with serious skepticism. At Northwest Compounds, every product we offer is accompanied by third-party COA documentation that goes beyond the basics. We believe researchers deserve to know exactly what they’re working with — and that accountability to quality standards is not optional in this space.   All products sold by Northwest Compounds LLC are strictly for Research Use Only (RUO). This article is provided for educational and informational purposes only.